SOLACE

Strengthening the screening of Lung Cancer in Europe

SOLACE aims at developing, testing and disseminating tools to help overcome identified bottlenecks and specifically address the health inequalities in different European countries. It will provide a toolbox for individualised approaches for lung cancer screening on a national or regional level.

Programme objectives:

• To facilitate and support the implementation of structured low-dose CT lung cancer screening programmes in Europe.
• To improve the quality of lung cancer screening across Europe.
• To improve the accessibility, benefit-harm balance, and cost effectiveness of lung cancer screening programmes.
• To bring together, for the first time, all key stakeholders needed to design, plan and implement LCS in member states on a sustainable basis.

Dr David Breen is the SOLACE lead for University of Galway-HSE West and North West. 

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.